Penaloza Lilly, Badiger Sanjeev, Shetty Avinash K
Department of Pediatrics and Office of Global Health, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
Department of Community Medicine, A. J. Institute of Medical Sciences, Mangalore, India.
Am J Trop Med Hyg. 2025 Jan 14;112(4):883-890. doi: 10.4269/ajtmh.24-0371. Print 2025 Apr 2.
India's National COVID Vaccination Program recommended vaccination of children ages 6-12 years in April 2022. This study assessed vaccine acceptance among mothers to better understand potential barriers and facilitators of national acceptance of pediatric coronavirus disease 2019 (COVID-19) vaccination. Qualitative data were collected through three focus group discussions (FGDs) with mothers who had children younger than 12 years of age; FGD-1 was composed of mothers who worked at a tertiary medical center in India, whereas FGD-2 and FGD-3 were composed of mothers who sought care at urban and rural community health centers. Investigators recorded, transcribed, translated, and analyzed FGDs by inductive thematic analysis. Emerging themes related to pediatric COVID-19 vaccination were categorized as knowledge and awareness, attitudes and perception, vaccine intent and facilitators, and future recommendations to promote vaccine uptake. FGD-2 and FGD-3 participants displayed limited knowledge and false beliefs regarding the pediatric COVID-19 vaccine, but mothers in FGD-1 demonstrated adequate knowledge, likely because they are health care providers. Mothers in all three FGDs expressed COVID-19 vaccine hesitancy because of concerns of side effects and low disease prevalence in children. They reported much more fear about giving the vaccine to their children than they felt about receiving it themselves. Overall, education was negatively correlated with vaccine knowledge, but mothers in all groups shared similar hesitancy about their intention to accept the vaccine for their children. Educating parents in India about the COVID-19 vaccine, especially its safety and efficacy in children, is crucial to the success of a national vaccine program.
印度国家新冠疫苗接种计划于2022年4月建议为6至12岁的儿童接种疫苗。本研究评估了母亲们对疫苗的接受程度,以更好地了解全国范围内接受儿童2019冠状病毒病(COVID-19)疫苗接种的潜在障碍和促进因素。通过与有12岁以下儿童的母亲进行三次焦点小组讨论(FGD)收集定性数据;FGD-1由在印度一家三级医疗中心工作的母亲组成,而FGD-2和FGD-3由在城市和农村社区卫生中心寻求医疗服务的母亲组成。研究人员通过归纳主题分析对FGD进行记录、转录、翻译和分析。与儿童COVID-19疫苗接种相关的新出现主题被归类为知识与认知、态度与看法、疫苗接种意愿与促进因素以及促进疫苗接种的未来建议。FGD-2和FGD-3的参与者对儿童COVID-19疫苗的知识有限且存在错误认知,但FGD-1中的母亲表现出了足够的知识,可能是因为她们是医疗保健提供者。所有三个FGD中的母亲都因担心副作用和儿童疾病患病率低而对COVID-19疫苗犹豫不决。她们表示,给孩子接种疫苗比自己接种疫苗更让她们害怕。总体而言,教育程度与疫苗知识呈负相关,但所有组的母亲在为孩子接种疫苗的意愿上都有类似的犹豫。在印度,对家长进行关于COVID-19疫苗的教育,尤其是其在儿童中的安全性和有效性,对于国家疫苗计划的成功至关重要。